drugset / Trial / NCT04597762

Effect of Ciclosporin Eyedrops on Sjögren Syndrome

NCT04597762

Completed 12 enrolled Hospital Hietzing
RandomizedParallel-groupSingle-blindTreatment

Summary

Keratoconjunctivitis sicca, also known as dry eye syndrome, is one of the most common ophthalmological diseases and is treated with tear substitutes to moisten the surface of the eye and, in more severe cases of this disease, with local anti-inflammatory therapy with corticosteroids or ciclosporin A. In patients with rheumatological diseases, such as Sjögren's syndrome, dry eye syndrome of severe extent occurs particularly frequently, which is why topical anti-inflammatory therapy is often necessary in these patients. Aim of this study is to evaluate the treatment of severe dry eye syndrome with topical cyclosporin eyedrops with and without topical corticosteroids at the beginning of the treatment.

Timeline

Start
2020-08-31
Primary completion
2021-03-30
Completion
2021-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide Topical
Subject Hydrocortisone Other / unclassified Topical

Indications